Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

被引:13
|
作者
Voeller, Heinz [1 ,2 ]
Gitt, Anselm [3 ]
Jannowitz, Christina [4 ]
Karoff, Marthin [5 ]
Karmann, Barbara [4 ]
Pittrow, David [6 ]
Reibis, Rona [1 ,7 ]
Hildemann, Steven [4 ,8 ]
机构
[1] Klin See, Dept Cardiol, Rudersdorf, Germany
[2] Univ Potsdam, Rehabil Res Ctr, D-14469 Potsdam, Germany
[3] Heidelberg Univ, Inst Herzinfarktforsch, D-69115 Heidelberg, Germany
[4] MSD Sharp & Dohme GmbH, Med Affairs & Klin Forsch, Haar, Germany
[5] Klin Univ Witten Herdecke, Klin Konigsfeld Deutsch Rentenversicherung Westfa, Witten, Germany
[6] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[7] Cardiol Outpatient Clin, Potsdam, Germany
[8] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 1, Bad Krozingen, Germany
关键词
Cardiac rehabilitation; registry; chronic kidney disease; glomerular filtration rate; dyslipidemia; control rates; risk factor; lipids; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RENAL-FUNCTION; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; EXERCISE;
D O I
10.1177/2047487313482285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) is a frequent comorbidity among elderly patients and those with cardiovascular disease. CKD carries prognostic relevance. We aimed to describe patient characteristics, risk factor management and control status of patients in cardiac rehabilitation (CR), differentiated by presence or absence of CKD. Design and methods: Data from 92,071 inpatients with adequate information to calculate glomerular filtration rate (GFR) based on the Cockcroft-Gault formula were analyzed at the beginning and the end of a 3-week CR stay. CKD was defined as estimated GFR <60 ml/min/1.73 m(2). Results: Compared with non-CKD patients, CKD patients were significantly older (72.0 versus 58.0 years) and more often had diabetes mellitus, arterial hypertension, and atherothrombotic manifestations (previous stroke, peripheral arterial disease), but fewer were current or previous smokers had a CHD family history. Exercise capacity was much lower in CKD (59 vs. 92Watts). Fewer patients with CKD were treated with percutaneous coronary intervention (PCI), but more had coronary artery bypass graft (CABG) surgery. Patients with CKD compared with non-CKD less frequently received statins, acetylsalicylic acid (ASA), clopidogrel, beta blockers, and angiotensin converting enzyme (ACE) inhibitors, and more frequently received angiotensin receptor blockers, insulin and oral anticoagulants. In CKD, mean low density lipoprotein cholesterol (LDL-C), total cholesterol, and high density lipoprotein cholesterol (HDL-C) were slightly higher at baseline, while triglycerides were substantially lower. This lipid pattern did not change at the discharge visit, but overall control rates for all described parameters (with the exception of HDL-C) were improved substantially. At discharge, systolic blood pressure (BP) was higher in CKD (124 versus 121 mmHg) and diastolic BP was lower (72 versus 74 mmHg). At discharge, 68.7% of CKD versus 71.9% of non-CKD patients had LDL-C <100 mg/dl. Physical fitness on exercise testing improved substantially in both groups. When the Modification of Diet in Renal Disease (MDRD) formula was used for CKD classification, there was no clinically relevant change in these results. Conclusion: Within a short period of 3-4 weeks, CR led to substantial improvements in key risk factors such as lipid profile, blood pressure, and physical fitness for all patients, even if CKD was present.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [41] Hypertension and cardiovascular risk in chronic kidney disease patients
    Luno, Jose
    Rodriguez-Iturbe, Bernardo
    Ayus, Juan Carlos
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 : S157 - S158
  • [42] EFFECT OF A CARDIAC REHABILITATION PROGRAM ON THE EVOKED INFLAMMATORY SIGNALING AS A RISK FACTOR IN PATIENTS WITH CARDIOVASCULAR DISEASE
    Lopez Frias, M.
    Gomez, M.
    Ramos, A.
    Sanchez, E.
    de Teresa, C.
    Diaz Castro, J.
    Ochoa, J.
    Nestares, T.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1187 - 1187
  • [43] EVALUATION OF HAEMOGRAM PARAMETERS AS A CARDIOVASCULAR RISK FACTOR IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
    Hancer, Hatike
    Kayabasi, Hasan
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 2027 - 2033
  • [44] In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor
    Agarwal, R.
    Pitt, B.
    Rossing, P.
    Anker, S. D.
    Filippatos, G.
    Ruilope, L. M.
    Kovesdy, C. P.
    Tuttle, K.
    Vaduganathan, M.
    Wanner, C.
    Bansilal, S.
    Gebel, M.
    Joseph, A.
    Lawatscheck, R.
    Bakris, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2420 - 2420
  • [45] Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease
    Sarafidis, Pantelis A.
    Sharpe, Claire C.
    Wood, Eleri
    Blacklock, Rochelle
    Rumjon, Adam
    Al-Yassin, Aziza
    Ariyanayagam, Rachel
    Simmonds, Shanique
    Fletcher-Rogers, Jessica
    Vinen, Katie
    NEPHRON CLINICAL PRACTICE, 2012, 120 (03): : C147 - C155
  • [46] Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors
    Price, Anna M.
    Edwards, Nicola C.
    Hayer, Manvir K.
    Moody, William E.
    Steeds, Richard P.
    Ferro, Charles J.
    Townend, Jonathan N.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2018, 12 (07) : 497 - 505
  • [47] Cardiovascular Risk Factor Burden and Treatment Control in Patients With CKD: The Fukuoka Kidney Disease Registry (FKR) Study
    Kitamura, Hiromasa
    Tanaka, Shigeru
    Hiyamuta, Hiroto
    Shimamoto, Sho
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 219 - 220
  • [48] FACTORS ASSOCIATED WITH THE FUNCTIONAL CAPACITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Reboredo, Maycon Moura
    Lawall Gravina, Emanuele Poliana
    Da Silva Jesus, Luciana Angelica
    Fonseca Lucinda, Leda Marilia
    Barros, Fabricio Sciammarella
    Fam Neto, Miguel Nunes
    Paula, Rogerio Baumgratz
    Pinheiro, Bruno Valle
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [49] Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk
    Vaduganathan, Muthiah
    Bhatt, Deepak L.
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (04) : 301 - 303
  • [50] Effect of a Virtual Cardiac Rehabilitation Program on Functional Capacity and Risk Factor Modification in Veterans With Ischemic Heart Disease
    Harzand, Arash
    Vakili, Alexander A.
    Davis-Watts, Michelle
    Nazar, Rene
    Wright, Phyllis
    Parrish, Cate G.
    Rout, Pratik
    Alrohaibani, Alaaeddin
    Shah, Amit J.
    CIRCULATION, 2020, 142